3 former pharmacy execs indicted
in alleged $50 million healthcare fraud scheme |
|||
Becker's Hospital Review |
|||
Three former executives of a Louisiana compounding pharmacy were
indicted in an alleged $50 million scheme to defraud New Jersey and military
health benefits programs. The three executives worked for Central Rexall
Drugs, a compounding pharmacy in Hammond, La. Christopher Johnston was
general counsel, Trent Brock was COO and Christopher Casseri was vice
president of sales. According to U.S. Attorney Craig Carpenito of the
District of New Jersey, the three men learned that some insurance plans —
including plans for New Jersey state and local government and education
employees and the military insurer Tricare — would reimburse thousands of
dollars for one-month supplies of some compounded drugs. |
|||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, September 23, 2020
3 former pharmacy execs indicted in alleged $50 million healthcare fraud scheme
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment